Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases,... Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Mehr anzeigen
Humacyte, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - HUMA PR Newswire LOS ANGELES, Jan. 17, 2025 LOS ANGELES, Jan. 17, 2025 /PRNewswire/ -- The...
The Gross Law Firm Notifies Shareholders of Humacyte, Inc.(HUMA) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Jan. 16, 2025 NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The...
Class Action Filed Against Humacyte, Inc. (HUMA) - January 17, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, Jan. 13, 2025 NEW YORK, Jan. 13, 2025 /PRNewswire/ -- The...
Investors in Humacyte, Inc. Should Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA PR Newswire NEW YORK, Jan. 9, 2025 NEW YORK, Jan. 9, 2025 /PRNewswire/ -- The...
Humacyte, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - HUMA PR Newswire NEW YORK, Jan. 6, 2025 NEW YORK, Jan. 6, 2025 /PRNewswire/...
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc.(HUMA) Shareholders PR Newswire NEW YORK, Jan. 2, 2025 NEW YORK, Jan. 2, 2025 /PRNewswire/ -- The...
Humacyte, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - HUMA PR Newswire LOS ANGELES, Jan. 2, 2025 LOS ANGELES, Jan. 2, 2025 /PRNewswire/ -- The DJS...
The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA PR Newswire NEW YORK, Dec. 30, 2024 NEW YORK...
Humacyte, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA PR Newswire NEW YORK, Dec. 26, 2024 NEW YORK, Dec. 26, 2024...
Investors in Humacyte, Inc. Should Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA PR Newswire NEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- The...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.08 | 1.77777777778 | 4.5 | 4.75 | 4.3 | 1973471 | 4.50984307 | CS |
| 4 | -0.84 | -15.4981549815 | 5.42 | 5.66 | 4.02 | 3605774 | 4.88152425 | CS |
| 12 | -0.54 | -10.546875 | 5.12 | 6.77 | 3.37 | 4844592 | 4.71472604 | CS |
| 26 | -3.59 | -43.94124847 | 8.17 | 9.79 | 3.37 | 3763935 | 5.38583949 | CS |
| 52 | 1.7 | 59.0277777778 | 2.88 | 9.97 | 2.8 | 2970551 | 5.45882921 | CS |
| 156 | -0.58 | -11.2403100775 | 5.16 | 9.97 | 1.96 | 1269948 | 5.06906739 | CS |
| 260 | -5.42 | -54.2 | 10 | 17.45 | 1.96 | 1178406 | 5.31107505 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
